Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Archives de pédiatrie
Volume 20, n° 5S1
pages H116-H117 (mai 2013)
Doi : 10.1016/S0929-693X(13)71349-6
TR26 – Bon usage des médicaments à visée osseuse dans l'enfance

Biothérapie de l’hypophosphatasie
 

J.-P. Salles
 Unité d’endocrinologie, maladies osseuses, gynécologie et génétique, Hôpital des Enfants, CHU de Toulouse ; INSERM U1043 ; CNRS U5282 ; Université de Toulouse Paul Sabatier, Centre de Physiopathologie de Toulouse Purpan (CPTP), France 


Top of the page

© 2013  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@